Sulfonylurea News and Research

RSS
Metformin for diabetics with renal damage scores over Sulphonylureas in terms of heart safety

Metformin for diabetics with renal damage scores over Sulphonylureas in terms of heart safety

Study shows metformin is safe for patients with mild-to- moderate kidney disease

Study shows metformin is safe for patients with mild-to- moderate kidney disease

Metformin use linked to lower risk of dementia in African Americans with type 2 diabetes

Metformin use linked to lower risk of dementia in African Americans with type 2 diabetes

FDA approves first non-insulin drug for treatment of pediatric patients with type 2 diabetes

FDA approves first non-insulin drug for treatment of pediatric patients with type 2 diabetes

Weight loss drug reduces risk of diabetes in patients with pre-diabetes, finds study

Weight loss drug reduces risk of diabetes in patients with pre-diabetes, finds study

Study changes clinical practice for children with diabetes

Study changes clinical practice for children with diabetes

SLU scientists receive grant to investigate link between diabetes drug and dementia risk

SLU scientists receive grant to investigate link between diabetes drug and dementia risk

ACP's clinical practice guidelines recommend effective treatment strategy for type 2 diabetes

ACP's clinical practice guidelines recommend effective treatment strategy for type 2 diabetes

New drug receives FDA approval to reduce risk of cardiovascular death in adults with diabetes

New drug receives FDA approval to reduce risk of cardiovascular death in adults with diabetes

FDA approves new injection to improve blood sugar levels in adults with type 2 diabetes

FDA approves new injection to improve blood sugar levels in adults with type 2 diabetes

Study highlights lack of guidance on deintensifying diabetic regimens

Study highlights lack of guidance on deintensifying diabetic regimens

Innovative treatment may help prevent brain swelling, death in stroke patients

Innovative treatment may help prevent brain swelling, death in stroke patients

Boehringer Ingelheim, Lilly announce availability of Synjardy tablets in U.S. pharmacies

Boehringer Ingelheim, Lilly announce availability of Synjardy tablets in U.S. pharmacies

EMPA-REG OUTCOME trial demonstrates superiority of Jardiance in T2D patients at risk for CV events

EMPA-REG OUTCOME trial demonstrates superiority of Jardiance in T2D patients at risk for CV events

Results from Intarcia's two phase 3 clinical trials of ITCA 650 to be presented at ADA's Scientific Session

Results from Intarcia's two phase 3 clinical trials of ITCA 650 to be presented at ADA's Scientific Session

Once-weekly Trulicity 0.75 mg shows promising results in Japanese patients with type 2 diabetes

Once-weekly Trulicity 0.75 mg shows promising results in Japanese patients with type 2 diabetes

New clinical data demonstrating treatment options in Lilly's diabetes portfolio to be presented at ADA Scientific Sessions

New clinical data demonstrating treatment options in Lilly's diabetes portfolio to be presented at ADA Scientific Sessions

Lilly Diabetes Alliance, Boehringer Ingelheim to present study results at ADA’s Scientific Sessions

Lilly Diabetes Alliance, Boehringer Ingelheim to present study results at ADA’s Scientific Sessions

Metformin can reduce risk of open-angle glaucoma in people with diabetes

Metformin can reduce risk of open-angle glaucoma in people with diabetes

IQWiG finds minor added benefit of dulaglutide in combination with short-acting insulin for type 2 diabetes

IQWiG finds minor added benefit of dulaglutide in combination with short-acting insulin for type 2 diabetes